On this episode of The Swallow Your Pride Podcast, Theresa sits down with Kate Hutcheson, PhD, CCC-SLP, BCS-S, Peter Belafsky, MD, M.P.H., PhD, and Andrew Tritter, MD, for a listening party unlike anything the dysphagia world has ever seen. What started as a dinner conversation at the Dysphagia Research Society about overrated anatomical structures became something none of them planned: a full-length AI-assisted music album called “One Night at La Reserve.” The album spans genres from blues to hip hop to prog rock and covers everything from the hyoid bone to cricopharyngeal dysfunction to patient-reported outcome measures. Theresa plays several tracks live on this episode, including “The Hyoid,” “Pharyngeal Jam,” “Rad Tox Blues,” “DIGEST,” and more. The album is available on iTunes and coming to Spotify, with proceeds supporting the National Foundation of Swallowing Disorders.
Podcast: Play in new window | Download
Subscribe: Apple Podcasts | Spotify | Amazon Music | Android | Pandora | iHeartRadio | RSS | More
Links: One Night at La Reserve – Apple Music and Spotify
Dr. Kate Hutcheson is a tenured Professor in the Departments of Head and Neck Surgery and Radiation Oncology at The University of Texas MD Anderson Cancer Center, and Section Chief of Speech Pathology and Audiology. She is an accomplished clinician and educator who leads an internationally recognized practice-oriented clinical research program in head and neck cancer survivorship funded by the NIH, PCORI, DOD, foundation and donor support.
Andrew Tritter, MD, is an Assistant Professor in the Department of Otorhinolaryngology-Head and Neck Surgery, where he directs the department’s Laryngology division, as well as the Texas Voice Performance Institute. He is a native Houstonian who obtained his undergraduate degree from Vanderbilt University in Spanish Linguistics and his medical degree from Baylor College of Medicine. Following medical school, Dr. Tritter went on to complete both an internship and residency in Otolaryngology-Head & Neck Surgery at the Louisiana State University in Shreveport before completing an additional year of fellowship training in Laryngology at Columbia University and Weill-Cornell Medical College in New York City. His experiences in fellowship afforded him extensive training in voice, airway, and swallowing disorders. Dr. Tritter is also a life-long musician and singer, which has greatly contributed to his interest in caring for patients with voice problems. Dr. Andrew Tritter has been recognized with numerous awards during his academic career, including membership in the Alpha Omega Alpha honor society. He has presented routinely at national conferences, and has multiple peer-reviewed publications in his field
Peter C. Belafsky, M.D., Ph.D., M.P.H. is Professor and the Director of the Center for Voice and Swallowing at the University of California, Davis. He is the also the Vice-chair of Academic Affairs for the Department of Otolaryngology at the UC Davis School of Medicine. He is past president of the Dysphagia Research Society and American Bronchoesophagological Society. He is the co-founder of the National Foundation of Swallowing Disorders, Reflux Gourmet, and HopeMedical. Dr. Belafsky’s research interests are focused on the development and application of innovative translational treatments for swallowing disorders. He has dedicated his career to building an internationally recognized Swallowing Center. The trans-disciplinary Center at UC Davis brings together outstanding physicians, speech and language pathologists, veterinarians, nutritionists, engineers, audiology technicians, general surgeons, gastroenterologists, and translational scientists to provide innovative approaches to the diagnosis and management of quaternary swallowing disorders. He has pioneered minimally invasive therapies including un-sedated treatment of laryngeal cancer, polyps, leukoplakia, and papilloma; tracheal and esophageal strictures; and office-based esophagoscopy. In October of 2010, he was the lead investigator on the second larynx transplant on a woman who had been unable to speak for over a decade. Dr. Belafsky has pioneered numerous treatments for small animals (cats/dogs) with profound swallowing and breathing disorders. His team has saved countless dogs and his work has led to innovations in both humans and animals. His trans-disciplinary approach has resulted in 6 first-in-human surgeries and 7 first-in-canine surgeries. He has over 200 publications, 5 textbooks, numerous patents, and has helped initiate 3 start-up companies based on technology he has developed at UC Davis. Dr. Belafsky remains frustrated with current treatment limitations and has dedicated his career to the development of innovative therapies to help suffering patients with complex swallowing impairment.
